Roivant Sciences Ltd
ROIV
Get informed when a big investor buys or sells
+ FollowMarket Cap$25.8B
Close$
$1.85
94.8% downside
Current Fair Value
94.8% downsideOvervalued by 94.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $25.80 Billion |
|---|---|
| Enterprise Value | $24.74 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.43 |
| Beta | 1.12 |
| Outstanding Shares | 720,776,739 |
Return
| Return on Equity | -6.29% |
|---|---|
| Return on Assets | -5.02% |
| Return on Invested Capital | -22.85% |
Valuation & Multiples
| P/E Ratio | -94 |
|---|---|
| PEG | 626.28 |
| Price to Sales | - |
| Price to Book Ratio | 5.95 |
| Enterprise Value to Revenue | 3284.28 |
| Enterprise Value to EBIT | -21.55 |
| Enterprise Value to Net Income | -93 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$2.07 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$3.74 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0562▲ 30.08% |
|---|---|
| Total Calls | 9,843,270▲ 638.15% |
| Total Puts | 10,396,000▲ 932.11% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 77.77%▲ 1.36% |
|---|---|
| Total Invested | $19.84B▲ 35.26% |
| Investors Holding | 518▲ 52.00% |
ESG Score
No data